TYRA vs. PRGO, AXSM, CORT, RARE, HCM, PBH, ARWR, FOLD, MRUS, and BHVN
Should you be buying Tyra Biosciences stock or one of its competitors? The main competitors of Tyra Biosciences include Perrigo (PRGO), Axsome Therapeutics (AXSM), Corcept Therapeutics (CORT), Ultragenyx Pharmaceutical (RARE), HUTCHMED (HCM), Prestige Consumer Healthcare (PBH), Arrowhead Pharmaceuticals (ARWR), Amicus Therapeutics (FOLD), Merus (MRUS), and Biohaven (BHVN). These companies are all part of the "pharmaceutical preparations" industry.
Perrigo (NYSE:PRGO) and Tyra Biosciences (NASDAQ:TYRA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.
Perrigo has a beta of 0.56, suggesting that its stock price is 44% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500.
Perrigo currently has a consensus price target of $40.67, suggesting a potential upside of 50.95%. Tyra Biosciences has a consensus price target of $23.50, suggesting a potential upside of 18.81%. Given Tyra Biosciences' stronger consensus rating and higher probable upside, equities research analysts plainly believe Perrigo is more favorable than Tyra Biosciences.
Perrigo has higher revenue and earnings than Tyra Biosciences. Perrigo is trading at a lower price-to-earnings ratio than Tyra Biosciences, indicating that it is currently the more affordable of the two stocks.
Perrigo received 745 more outperform votes than Tyra Biosciences when rated by MarketBeat users. Likewise, 66.78% of users gave Perrigo an outperform vote while only 63.33% of users gave Tyra Biosciences an outperform vote.
Tyra Biosciences has a net margin of 0.00% compared to Tyra Biosciences' net margin of -0.17%. Tyra Biosciences' return on equity of 6.96% beat Perrigo's return on equity.
95.9% of Perrigo shares are held by institutional investors. Comparatively, 84.1% of Tyra Biosciences shares are held by institutional investors. 0.7% of Perrigo shares are held by insiders. Comparatively, 15.4% of Tyra Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Tyra Biosciences had 1 more articles in the media than Perrigo. MarketBeat recorded 5 mentions for Tyra Biosciences and 4 mentions for Perrigo. Tyra Biosciences' average media sentiment score of 1.11 beat Perrigo's score of 0.70 indicating that Perrigo is being referred to more favorably in the media.
Summary
Perrigo beats Tyra Biosciences on 11 of the 16 factors compared between the two stocks.
Get Tyra Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TYRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tyra Biosciences Competitors List
Related Companies and Tools
